Our data further revealed a decreased number of CD8+ T cells in HCC with high TBK1 expression, and no significant prognostic value of TBK1 expression in HCC patients with enriched tumoral CD8+ T cells. This evidence concerns the gene CD8A and hepatocellular carcinoma.